Kane Biotech Inc. (TSXV:KNE)
Canada
· Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
Apr 29, 2026, 9:47 AM EST
Kane Biotech Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.9 | 0.36 | 0.75 | 1.1 | 1.15 | Upgrade
|
| Cash & Short-Term Investments | 0.9 | 0.36 | 0.75 | 1.1 | 1.15 | Upgrade
|
| Cash Growth | 151.30% | -52.11% | -32.19% | -4.18% | 14.40% | Upgrade
|
| Accounts Receivable | 0.01 | 0.01 | 0 | 0.32 | 0.18 | Upgrade
|
| Other Receivables | 0.02 | 0.07 | 0.1 | 0.74 | 0.89 | Upgrade
|
| Receivables | 0.04 | 0.09 | 0.1 | 1.06 | 1.07 | Upgrade
|
| Inventory | 0.5 | 0.38 | 0.25 | 0.76 | 0.52 | Upgrade
|
| Prepaid Expenses | 0.25 | 0.21 | 0.15 | - | - | Upgrade
|
| Other Current Assets | - | - | 2.47 | 0.17 | 0.14 | Upgrade
|
| Total Current Assets | 1.69 | 1.03 | 3.72 | 3.1 | 2.88 | Upgrade
|
| Property, Plant & Equipment | 0.48 | 0.93 | 1.07 | 1.25 | 1.44 | Upgrade
|
| Other Intangible Assets | 0.57 | 0.54 | 0.73 | 0.83 | 0.83 | Upgrade
|
| Other Long-Term Assets | - | - | 0.16 | 0.44 | 0.86 | Upgrade
|
| Total Assets | 2.73 | 2.49 | 5.68 | 5.62 | 6.13 | Upgrade
|
| Accounts Payable | 0.69 | 1.01 | 0.44 | 0.6 | 0.63 | Upgrade
|
| Accrued Expenses | 0.38 | 0.64 | - | - | - | Upgrade
|
| Short-Term Debt | - | - | 6.63 | 4.01 | 2.39 | Upgrade
|
| Current Portion of Long-Term Debt | 1.25 | 0.34 | 0.34 | 0.17 | - | Upgrade
|
| Current Portion of Leases | 0.08 | 0.12 | 0.11 | 0.1 | 0.13 | Upgrade
|
| Current Unearned Revenue | - | - | 0.75 | 0.21 | 0.14 | Upgrade
|
| Other Current Liabilities | 0.1 | 0.3 | 2.62 | 1.24 | 1.43 | Upgrade
|
| Total Current Liabilities | 2.5 | 2.41 | 10.89 | 6.34 | 4.72 | Upgrade
|
| Long-Term Debt | 0.62 | 0.96 | 1.3 | 1.6 | 1.12 | Upgrade
|
| Long-Term Leases | 0.36 | 0.76 | 0.87 | 0.98 | 1.09 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 0.19 | 0.84 | 0.78 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.83 | - | - | Upgrade
|
| Total Liabilities | 3.48 | 4.12 | 14.09 | 9.76 | 7.7 | Upgrade
|
| Common Stock | 27.97 | 24.4 | 23.69 | 23.13 | 22.16 | Upgrade
|
| Additional Paid-In Capital | 8.41 | 8.32 | 7.75 | 7.44 | 5.51 | Upgrade
|
| Retained Earnings | -37.14 | -34.42 | -42.13 | -37.1 | -33.21 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.07 | 0.14 | - | 1.66 | Upgrade
|
| Total Common Equity | -0.75 | -1.63 | -10.56 | -6.52 | -3.89 | Upgrade
|
| Minority Interest | - | - | 2.15 | 2.38 | 2.32 | Upgrade
|
| Shareholders' Equity | -0.75 | -1.63 | -8.41 | -4.14 | -1.57 | Upgrade
|
| Total Liabilities & Equity | 2.73 | 2.49 | 5.68 | 5.62 | 6.13 | Upgrade
|
| Total Debt | 2.3 | 2.18 | 9.26 | 6.86 | 4.72 | Upgrade
|
| Net Cash (Debt) | -1.4 | -1.82 | -8.51 | -5.76 | -3.57 | Upgrade
|
| Net Cash Per Share | -0.01 | -0.01 | -0.07 | -0.05 | -0.03 | Upgrade
|
| Filing Date Shares Outstanding | 181.86 | 154.77 | 131.84 | 124.85 | 114.83 | Upgrade
|
| Total Common Shares Outstanding | 181.6 | 137.79 | 131.84 | 124.83 | 114.81 | Upgrade
|
| Working Capital | -0.81 | -1.38 | -7.17 | -3.24 | -1.84 | Upgrade
|
| Book Value Per Share | -0.00 | -0.01 | -0.08 | -0.05 | -0.03 | Upgrade
|
| Tangible Book Value | -1.31 | -2.17 | -11.29 | -7.35 | -4.71 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.02 | -0.09 | -0.06 | -0.04 | Upgrade
|
| Machinery | 0.32 | 0.42 | 0.4 | 0.51 | 0.47 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.